Drug‐Coated Balloon Versus Drug‐Eluting Stent for Large Coronary Arteries in Patients Presenting With STEMI: A Systematic Review and Meta‐Analysis
Catheterization and Cardiovascular Interventions · 2026
DOI: 10.1002/ccd.70358 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Catheterization and Cardiovascular Interventions, 2026. Verfasst von Ahmed Mohamed Elbeny und 10 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular Department, Faculty of Medicine, Al-Azhar University, Cairo, Egypt. Hauptthemen laut MEDLINE: Drug-Eluting Stents, ST Elevation Myocardial Infarction, Coated Materials, Biocompatible, Cardiac Catheters. Die Arbeit nennt 25 Literaturangaben. Gefördert von: The authors received no specific funding for this work..
Abstract (Originalsprache)
Drug‐coated balloons (DCB) have emerged as a promising stentless strategy in percutaneous coronary intervention, but their role in ST‐elevation myocardial infarction (STEMI) involving large de novo coronary arteries remains uncertain. This systematic review and meta‐analysis evaluated the clinical and angiographic outcomes of DCB compared with drug‐eluting stents (DES) in STEMI patients with large bservational cohorts. The primary outcomes were target lesion revascularization (TLR), major adverse cardiac events (MACE), myocardial infde novo coronary lesions (≥ 2.5 mm). A comprehensive search of PubMed, Scopus, and Web of Science was performed up to July 1, 2025, including randomized controlled trials, non‐randomized trials, and oarction (MI), and cardiac and all‐cause death; angiographic endpoints included minimal lumen diameter (MLD) post‐PCI and at follow‐up, and late lumen loss (LLL). Four studies comprising 1428 patients were included. There were no significant differences between DCB and DES in TLR (RR = 1.16, 95% CI: 0.62–2.17, p = 0.65), MACE (RR = 1.59, 95% CI: 0.64–3.97, p = 0.32), cardiac death (RR = 1.07, 95% CI: 0.55–2.09, p = 0.84), or MI (RR = 1.20, 95% CI: 0.77–1.87, p = 0.42). Post‐PCI MLD was significantly higher with DES (MD = –0.29 mm, 95% CI: –0.39 to –0.20, p < 0.00001), whereas follow‐up MLD did not differ significantly between groups (MD = –0.26 mm, 95% CI: –0.62 to 0.11, p = 0.17). LLL was comparable (MD = 0.02 mm, 95% CI: –0.08 to 0.11, p = 0.73). These findings suggest that DCB represents a safe and effective alternative to DES in STEMI patients with large de novo coronary artery lesions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cardiovascular Department, Faculty of Medicine, Al-Azhar University, Cairo, Egypt.
- Faculty of Medicine, Al-Azhar University, Cairo, Egypt.
ORCID-Profile: Atef A Hassan
Förderung
- The authors received no specific funding for this work.
Zitieren
APA
Elbeny, A. M., Elkasaby, M. H., Fouad, T. A., Soltan, M. E., Abdelaziz, A. S., Metwally, A. E., Othman, M. A., Gebali, M. M., Muharram, M. A., Abdo, A. A., & Hassan, A. A. (2026). Drug‐Coated Balloon Versus Drug‐Eluting Stent for Large Coronary Arteries in Patients Presenting With STEMI: A Systematic Review and Meta‐Analysis. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.70358
Vancouver
Elbeny AM, Elkasaby MH, Fouad TA, Soltan ME, Abdelaziz AS, Metwally AE, et al. Drug‐Coated Balloon Versus Drug‐Eluting Stent for Large Coronary Arteries in Patients Presenting With STEMI: A Systematic Review and Meta‐Analysis. Catheterization and Cardiovascular Interventions. 2026. doi:10.1002/ccd.70358
BibTeX
@article{Elbeny2026,
author = {Elbeny, Ahmed Mohamed and Elkasaby, Mohamed Hamouda and Fouad, Tamer Ahmed and Soltan, Mostafa Elrefay and Abdelaziz, Ahmed Saeed and Metwally, Abdelrahman E and Othman, Muhammad Abdullah and Gebali, Mahmoud Mohammad and Muharram, Mohamed Ahmed and Abdo, Ahmed Ali and Hassan, Atef A},
title = {Drug‐Coated Balloon Versus Drug‐Eluting Stent for Large Coronary Arteries in Patients Presenting With STEMI: A Systematic Review and Meta‐Analysis},
journal = {Catheterization and Cardiovascular Interventions},
year = {2026},
doi = {10.1002/ccd.70358}
}
EUVIMED